Macrophage-derived macrophage migration inhibitory factor mediates renal injury in anti-glomerular basement membrane...

Area of Science:

• Immunology
• Nephrology
• Molecular Biology

Background:

• Macrophages are key immune cells implicated in kidney injury.
• Macrophage migration inhibitory factor (MIF) is a cytokine produced by macrophages.
• Both macrophages and MIF are known to contribute to anti-glomerular basement membrane crescentic glomerulonephritis (anti-GBM CGN).

Purpose of the Study:

• To investigate the specific role of macrophage-derived MIF in the pathogenesis of anti-GBM CGN.
• To determine if targeting macrophage MIF can ameliorate anti-GBM CGN.

Main Methods:

• Utilized MIF^f/f-lysM-cre mice for conditional ablation of MIF in macrophages.
• Induced anti-GBM CGN in MIF^f/f-lysM-cre and control MIF^f/f mice.
• Assessed kidney injury markers (serum creatinine, proteinuria, creatine clearance), glomerular crescent formation, and immune cell infiltration.
• Analyzed macrophage polarization (M1/M2) and T cell responses (Treg, Th1, Th17).

Main Results:

• Conditional deletion of MIF in macrophages significantly suppressed anti-GBM CGN.
• Reduced glomerular crescent formation, serum creatinine, and proteinuria, while improving creatine clearance.
• Inhibited renal macrophage and T cell recruitment.
• Promoted M2 macrophage polarization via the CD74/NF-κB/p38MAPK pathway.
• Increased regulatory T cell (Treg) populations and suppressed Th1/Th17 responses.

Conclusions:

• Macrophage-derived MIF plays a critical pathogenic role in anti-GBM CGN.
• Targeting macrophage MIF ameliorates kidney injury in this model.
• Macrophage MIF inhibition offers a potential therapeutic strategy for immune-mediated kidney diseases.